Is capillary ketone determination useful in clinical practice? In which circumstances?

Diabetes and Metabolism

Volumn 31, Issue 3 I, 2005, Pages 299-303

  Meas, T ^b   Taboulet, P ^b   Sobngwi, E ^b   Gautier, J F ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

3 hydroxybutyrate; Ketoacidosis; Ketonemia; Ketonuria; Self monitoring

Indexed keywords

GLUCOSE; INSULIN; INSULIN LISPRO; KETONE; SULFONYLUREA DERIVATIVE;

ADOLESCENT; ANALYTIC METHOD; ARTICLE; AUTOANALYSIS; CAPILLARY; CLINICAL PRACTICE; DIABETIC KETOACIDOSIS; DRUG INFUSION; EMERGENCY WARD; EQUIPMENT; FEMALE; GLUCOSE BLOOD LEVEL; HOME MONITORING; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KETONEMIA; KETONURIA; MEASUREMENT; METABOLIC DISORDER; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT CARE; PREGNANCY DIABETES MELLITUS; QUANTITATIVE ANALYSIS; URINALYSIS;

EID: 21844434220     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70198-2     Document Type: Article

References (22)

1. Laffel L. Ketone bodies, a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev, 1999, 15, 412-26.
2. Reichard GA Jr, Owen OE, Haff AC, Paul P, Bortz WM. Ketone-body production and oxidation in fasting obese Humans. J Clin Invest, 1974, 53, 508-15.
3. Serra D, Casals N, Asins G, Royo T, Ciudad CJ, Hegardt FG. Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes. Arch Biochem Biophys, 1993, 307, 40-5.
4. Bartels PD, Lund-Jacobsen H. Blood lactate and ketone body concentrations in salicylate intoxication. Hum Toxicol, 1986, 5, 363-6.
5. Laffel L, Loughlin CA, Tovar A, Zuehlke JB, Moltz KC, Miller M, Brink S. Sick day management (SDM) using blood beta-hydroxybutyrate vs. Urine ketone significantly reduces hospital visits in youth with TIDM, randomized clinical trail. Diabetes, 2002, 51 (Suppl 2), 426-P.
6. Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin North Am, 2000, 29, 707-23.
7. ADA. Tests of glycemia in diabetes. Diabetes Care, 2004, 27 (suppl 1), S91-S93.
8. Rosenbloom AL, Malone JI. Recognition of impending ketoacidosis delayed by ketone reagent strip failure. JAMA, 1978, 240, 2462-4.
9. Byrne HA, Tieszen KL, Hollis S, et al. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care, 2000, 23, 500-3.
10. Guerci B, Benichou M, Floriot M, Bohme P, Fougnot S, Franck P, Drouin P. Accuracy of an electrochemical sensor for measuring capillary blood ketones by finger stick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care, 2003, 26, 1137-41.
11. Taboulet P, Hass H, Porcher R, Manamani J, Fontaine JP, Feugeas JP, Gautier JF. Urinary acetoacetate or capillary B-hydroxybutyrate for the diagnosis of ketoacidosis in the emergency department setting. Eur J of Emerg Med, 2004, 11, 251-8.
12. Schwab TM, Hendey GW, Soliz TC. Screening for ketonemia in patients with diabetes. Ann Emerg Med, 1999, 34, 342-346.
13. Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care, 1997, 20, 1347-1352.
14. Fineberg SE, Brink S, Kaufman F. Comparison of blood beta-hydroxybutyrate and urine ketones in 4 weeks of home monitoring by insulin-requiring children and adults. Diabetes, 2000, 49 (Suppl 2), A105.
15. Laffel L, Brink S, Kaufman F. Frequency of elevation in blood beta-hydroxybutyrate during home monitoring and association with glycemia in insulin-treated children and adults. Diabetes, 2000, 49 (Suppl 2), A92.
16. Wallace TM, Meston NM, Gardner SG, et al. The hospital and home use of a 30-second hand-held blood ketone meter, guidelines for clinical practice. Diabet Med, 2001, 18, 640-5.
17. Harano Y, Kosugi K, Hyosu T, et al. Ketone bodies as markers for type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control. Diabetologia, 1984, 26, 343-348.
18. Delcroix C, Bruno F. Faisabilité, Acceptabilité et intérêt pratique du dosage de la cétonémie chez l'enfant DID. Diabetes Metab, 2002, 28 (hors série), 1S76.
19. Samuelsson U, Ludvigsson J. When should determination of ketonemia be recommended? Diabetes Technol Ther, 2002, 4, 645-50.
20. Krzentowski G, Scheen A, Castillo M, et al. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia, 1983, 24, 314-8.
21. Melki V, Bessierres-Lacombe S. Autosurveillance capillaire de la cétonémie, valeurs normales chez les diabétiques de type 1 traités par pompe externe et lispro. Diabètes Metab, 2002, 28 (hors série) 1S74.
22. Mosnier-Pudhar H, Cuperlier A, Le Dévéhat C, et al. Mise en place et validation de recommandations de traitement et de surveillance basés sur la détermination capillaire des corps cétoniques chez le patient diabétique en cétose (résultats intermédiaires). Diabètes Metab, 2003, 29, 1S52.